|
EID1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.39009914690291E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87994064759778E-12 |
| Normal-vs-Stage2 |
7.882400E-02 |
| Normal-vs-Stage3 |
5.216500E-04 |
| Normal-vs-Stage4 |
5.352500E-02 |
| Stage1-vs-Stage2 |
4.643400E-01 |
| Stage1-vs-Stage3 |
1.603010E-01 |
| Stage1-vs-Stage4 |
2.662800E-01 |
| Stage2-vs-Stage3 |
9.806600E-01 |
| Stage2-vs-Stage4 |
9.261800E-01 |
| Stage3-vs-Stage4 |
8.498000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44966286039516E-12 |
| Normal-vs-AfricanAmerican |
2.770400E-04 |
| Normal-vs-Asian |
2.405200E-04 |
| Caucasian-vs-AfricanAmerican |
2.369600E-01 |
| Caucasian-vs-Asian |
7.924600E-01 |
| AfricanAmerican-vs-Asian |
5.522400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.41549052665869E-14 |
| Normal-vs-Female |
6.236700E-03 |
| Male-vs-Female |
1.918090E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.52740000000096E-05 |
| Normal-vs-Extreme_Weight |
1.84290360749628E-11 |
| Normal-vs-Obese |
3.1007999999888E-06 |
| Normal-vs-Extreme_Obese |
1.455560E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.756000E-01 |
| Normal_Weight-vs-Obese |
7.314600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.942000E-01 |
| Extreme_Weight-vs-Obese |
1.665990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.982400E-01 |
| Obese-vs-Extreme_Obese |
3.808000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.573790E-01 |
| Normal-vs-Age(41-60Yrs) |
3.31810000031574E-07 |
| Normal-vs-Age(61-80Yrs) |
1.76203496238259E-12 |
| Normal-vs-Age(81-100Yrs) |
3.619700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.288000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.314200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.602000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.154370E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.526570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.250000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.9886982605708E-11 |
| Normal-VS-Type2 PRCC |
7.06130043326425E-10 |
| Normal-VS-KIRP CIMP |
9.554600E-01 |
| Normal-VS-Unclassified PRCC |
2.70000000024417E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.818600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.005200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.763000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.681750E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.499200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.080600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.03650000033073E-07 |
| Normal-vs-N1 |
4.355000E-03 |
| Normal-vs-N2 |
1.621040E-01 |
| N0-vs-N1 |
2.066400E-01 |
| N0-vs-N2 |
9.838600E-01 |
| N1-vs-N2 |
5.051200E-01 |
|
|
